Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Heptaminol Hydrochloride for Hypotension Prevention in Spinal Anesthesia
NCT06564935Phase 3Not yet recruiting
- Sponsor
- Cairo University
- Start
- Aug 2024
- Primary completion
- Feb 2025
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of heptaminol in hypotension, sponsored by Cairo University. Planned start Aug 2024; status: not yet recruiting.
02
Drugs
heptaminol
03
Conditions
hypotension
Beyond the preview
Go deeper on NCT06564935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06564935.